Rajendra Vs. State of Maharashtra [Bombay High Court, 102016]

October 14, 2016

In Rajendra s/o Madhav Pate Vs. State of Maharashtra & Anr. (Criminal Writ Petition No. 846 of 2016, decided on October 10, 2016), the Bombay High Court Aurangabad Bench quashed criminal proceedings initiated under the Drugs and Cosmetics Act, 1940. Justices S.S. Shinde and Sangitrao S. Patil ruled that non-cognizable offences under Section 27(b)(ii) cannot be prosecuted through a police chargesheet and require a formal complaint by an authorized Drugs Inspector under Section 32.

Factual Background and Inception of Prosecution

The petitioner, Rajendra s/o Madhav Pate, a 49-year-old businessman residing in Chalisgaon, District Jalgaon, was engaged in the retail and wholesale distribution of medicines. Following an inspection of his commercial premises, the Drugs Inspector alleged that the petitioner had sold pharmaceutical preparations during a period when his wholesale drug licence was temporarily suspended by licensing authorities. Instead of filing a statutory private complaint before the jurisdictional Judicial Magistrate, the Drugs Inspector lodged a First Information Report (FIR) with the local police station.

The police registered the FIR, commenced a regular investigation, and submitted a final charge sheet under Section 173 of the Code of Criminal Procedure, 1973 (CrPC). Acting on this police report, the Judicial Magistrate First Class, Chalisgaon, took cognizance of the offence and registered Summary Criminal Case No. 671 of 2014. The petitioner challenged the entire criminal proceeding by filing a writ petition under Article 226 of the Constitution of India read with Section 482 of the CrPC, asserting that the Magistrate had no legal jurisdiction to take cognizance based on a police report.

Statutory Framework Governing Drug Prosecutions

The High Court conducted a detailed analysis of the statutory interplay between the Drugs and Cosmetics Act, 1940 and the general provisions of the Code of Criminal Procedure:

  • Section 32 of the Drugs and Cosmetics Act: Expressly mandates that no prosecution under Chapter IV shall be instituted except by a Drugs Inspector, an officer authorized by the Government, or an aggrieved person.
  • Classification of Offences under Section 36AC: Only specific severe offences relating to adulterated, spurious, or substandard drugs causing death or grievous hurt are declared cognizable under Section 27(a). Regulatory licensing offences under Section 27(b)(ii) remain non-cognizable.
  • Definition of Complaint under Section 2(d) CrPC: A formal written allegation made to a Magistrate seeking judicial action, which explicitly excludes a police report.
  • Conditions for Taking Cognizance under Section 190 CrPC: Magistrates must take cognizance strictly in conformity with statutory pre-conditions specified in special enactments.
  • Investigation into Non-Cognizable Offences: Section 155(2) CrPC bars police officers from investigating non-cognizable offences without an explicit order from a competent Magistrate.

Distinction Between Cognizable Adulteration and Regulatory Violations

The statutory scheme of the Drugs and Cosmetics Act maintains a clear demarcation between severe public health menaces and technical licensing contraventions. Under Section 36AC, offences under Section 27(a) and Section 27(c) concerning adulterated or spurious drugs that cause death or grievous bodily harm are made cognizable and non-bailable, allowing direct police intervention. Conversely, technical violations under Section 27(b)(ii) concerning manufacture or distribution without a valid licence are non-cognizable.

For these non-cognizable regulatory offences, the law explicitly relies upon the specialized expertise of the Drugs Inspectorate. The police cannot bypass this legislative safeguard by treating regulatory non-compliance as a general criminal offence under the Indian Penal Code or filing chargesheets under Section 173 CrPC without judicial authorization.

High Court Legal Analysis and Quashing of Proceedings

The Division Bench observed that the Drugs and Cosmetics Act is a specialized, self-contained enactment. The legislature enacted Section 32 to guarantee that pharmaceutical prosecutions are initiated exclusively by technically qualified Drugs Inspectors who understand medicine standards, batch records, storage rules, and licensing procedures.

Because an offence under Section 27(b)(ii) is non-cognizable, the police lacked statutory authority to register an FIR, conduct an investigation without a Magistrate order under Section 155(2) CrPC, or submit a charge sheet under Section 173(2) CrPC. The Judicial Magistrate committed a fundamental jurisdictional error by taking cognizance of the offence based on a police report under Section 190(1)(b) CrPC instead of a complaint under Section 190(1)(a) CrPC. Such an error constitutes an incurable defect under Section 461(k) of the Code. In reviewing this procedural illegality, the Bench applied established Bombay High Court criminal review standards regarding mandatory procedural compliance in criminal trials.

Special Act Primacy over General Criminal Law

The judgment reinforces the established legal maxim generalia specialibus non derogant (special law overrides general law). When a special statute prescribes a particular procedure for instituting criminal proceedings, that procedure must be strictly followed, and all other modes are impliedly excluded. Bypassing the mandatory complaint procedure under Section 32 of the Drugs and Cosmetics Act renders the entire criminal prosecution void ab initio. The High Court held that allowing the trial to continue would result in an abuse of the process of the court.

Consequently, the Bombay High Court allowed the criminal writ petition, quashed the police charge sheet, and set aside all proceedings in Summary Criminal Case No. 671 of 2014 pending before the Judicial Magistrate First Class, Chalisgaon.

Practical Implications for Pharmaceutical Businesses and Litigants

The decision in Rajendra Vs. State of Maharashtra provides valuable guidance for pharmaceutical distributors, retailers, and legal practitioners:

  1. Prompt Challenge to Police Interventions: When police register FIRs for non-cognizable offences under the Drugs and Cosmetics Act, businesses should promptly seek quashing under Section 482 CrPC or Article 226.
  2. Enforcing Statutory Procedure: Regulatory inspectors must file formal private complaints before Magistrates rather than delegating enforcement to police stations.
  3. Early Scrutiny of Cognizance Orders: Defence counsel should verify the legal basis of cognizance at the summons stage to challenge cases founded on unauthorized police reports.
  4. Protection Against Unlawful Harassment: Special statute protections prevent arbitrary police interference in regulated commercial trades.
  5. Jurisdictional Sanctity in Special Statues: Criminal courts cannot circumvent statutory complaint requirements by entertaining police chargesheets for non-cognizable violations.

This ruling upholds statutory discipline under the Drugs and Cosmetics Act, ensuring that criminal prosecutions against licensed traders adhere strictly to the rule of law.

Found this helpful?

Share this page with others